Monday, December 23, 2024
HomeTagsAccessible Portfolio

Accessible Portfolio

Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests

Delfi Diagnostics, Inc., a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, announced a...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics